You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company, which launched the technology in September 2019, said in its Q4 earnings release that it received high marks from beta testers.
The firm also has an early-access program for a new amplification strategy that combines 11 HLA genes for typing.
In a retrospective analysis, UK researchers found that long-read sequencing of HLA genes in stem cell transplantation donors and recipients led to better outcomes.
Japanese researchers developed a catalog of HLA alleles that they used to perform a phenome-wide association study of the MHC and about a hundred phenotypes.
The index's 13 percent gain was below the 39 percent surge of 2017 but occurred despite the poor performance of index stocks in December.
The company also said it launched a new comprehensive diagnostic called HeartCare for surveillance of heart transplant patients.
The team used genetic scoring to identify infants without a family history of the disease who had more than a 10 percent risk for developing islet antibodies.
The firm says its Olerup QType test is available on both Roche and Applied Biosystems platforms.
The workflow was cleared by the South Korean Ministry of Food and Drug Safety for the typing of HLA-A, B, C, DRB1, and DQB1 by next-generation sequencing.
The Boston-based startup wants to help individuals interpret their HLA data for ancestry and health, and participate in research studies.
A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.
NPR reports that some insect pests are now becoming resistant to Bt crops.
Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.
In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.